BFM Podcast
从疫苗商战到国家战略 专访疫苗制造商康希诺
27-Jul-22 08:00
成立于2009年的康希诺生物，是中国从事疫苗的研发、生产和商业化公司，这家公司不但建立了基于病毒载体技术、合成疫苗技术等核心的技术平台，而且还特别建立了针对12个疾病领域，像是新冠肺炎病毒还有伊波拉病毒等的研发管线。值得注意的是，他们所研发的新冠疫苗克威莎，不但被世界卫生组织列入紧急使用清单，马来西亚政府也批准这款疫苗为混打疫苗。
康希诺生物执行董事，兼联合创办人邱东旭到我们的节目中，来跟我们分享公司在过去2年到底是如何对抗新冠肺炎疫情，还有疫苗研发对一个国家战略的重要性。
More articles on BFM Podcast
A Future-Ready Medical Program at Sir Jeffrey Cheah Sunway Medical School
Created by Tan KW | Nov 21, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
THE INVESTMENT APPROACH OF CALVIN TAN
2
Koon Yew Yin's Blog
3
save malaysia!
5
6
7
8
Mercury Securities Research
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
MQ Trading Signals
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
